Expired Canadian patentCanada
Selection of proteins using rna-protein fusions
CA 2361725 C · Owner: The General Hospital Corporation · Inventors: Roberts, Richard W.; Szostak, Jack W.; Liu, Rihe
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Described herein are RNA-protein fusion production methods which involve a high salt post-translational incubation step.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 1, 2000 and granted April 12, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended February 1, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 1, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledFebruary 1, 2000
GrantedApril 12, 2011
Term endedFebruary 1, 2020
Patent numberCA 2361725 C
Classification (IPC)C07H21/04 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.